摘要
目的探讨凝血和纤溶实验室指标变化对妊娠期高血压患者的临床意义。方法选取2015年12月至2016年12月在大连市妇幼保健院就诊的妊娠期高血压患者100例,为研究组和正常体检孕妇100例为对照组,比较两组患者凝血和纤溶。结果研究组血浆凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)和纤维蛋白原(FIB)含量,D-D二聚体(DD)均高于对照组,差异有统计学意义(P<0.05)。结论妊娠期高血患者体内存在高凝转态,检测患者的PT、APTT、FIB、DD,可以预防和治疗妊娠期高血压,具有重要意义。
Objective To study the blood coagulation and fibrinolysis laboratory indicators in the clinical significance in patients with gestational hypertension. Methods Select in December 2015 to December 2016 in dalian city maternal and child health care of 100 patients with gestational hypertension, as research group and normal physical examination, 100 cases of pregnant women as control group, Compare two groups of patients with blood coagulation and fibrinolysis. Results The team plasma prothrombin time（PT）, activated partial clotting enzyme live time（APTT） and fibrinogen（FIB） content, D-D dimer（DD） were higher than the control group, the difference was statistically significant（P〈0.05）. Conclusion Pregnancy patients with high blood in the body of high coagulation state, detecting PT, APTT, FIB, in patients with DD, can prevent and treat hypertension during pregnancy, it is of great significance.
出处
《中国医药指南》
2018年第7期10-11,共2页
Guide of China Medicine
关键词
凝血
纤溶
妊娠期高血压
Blood coagulation
Fibrinolytic
Gestational hypertension
